Small Bone Innovations, Inc. Strengthens Senior Management & Announces Formation of Executive Committee

Share this story with your network

NEW YORK–(BUSINESS WIRE)–Small Bone Innovations, Inc. (SBi), a single-source provider of innovation, products, technology and education for the small bone & joint (SB&J) sector of the orthopedics industry, announced that it has strengthened its Senior Management and also formed its Executive Management Team.

SBi is announcing that Steve D. Ward, in addition to being the company’s Chief Financial Officer (CFO) since March of 2006, has been promoted to the Chief Operating Officer (COO) role. This opening was created by the recent retirement of Robert W. Churinetz, who was the company’s COO. After successfully leading SBi’s effort to transition from a manufacturing to a supply-chain focus by divesting U.S. and French manufacturing operations and installing a multi-tiered manufacturing vendor management system, Mr. Churinetz will be joining Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA) to help build their manufacturing, quality assurance and international regulatory practice serving orthopedic companies throughout the world. Through this affiliation, he will continue to help SBi and focus his energy on transferring manufacturing of the Scandinavian Total Ankle Replacement (S.T.A.R.) Ankle from Waldemar Link GmbH in Hamburg, Germany to a new manufacturing location.

Anthony G. Viscogliosi, Chairman & CEO of SBi, said: “SBi has benefited greatly from Bob’s operational know-how and extensive SB&J experience since he joined the company in July of 2006. We wish Bob well on his new endeavors and believe that his background is highly additive to the team that is already in place at MCRA. We are also grateful to have an executive of Steve’s caliber, whose background includes operational experience having overseen logistics, customer service and facilities operations at his prior firm, to step in to ensure a seamless transition.”

SBi is also announcing that it has formed an Executive Management Committee, which consists of Anthony G. Viscogliosi (Chairman & CEO), Thomas Crowley (President), Florian Kemmerich (President, SBi International) and Steve Ward (CFO/COO). Mr. Kemmerich’s addition to SBi was described in a press release issued on February 17th, 2009. Based upon the Board of Director’s agreed upon corporate goals, as developed by the CEO, this team of executive management determines the company’s objectives, business strategies and oversees the execution of these plans to achieve the goals.

Additionally, SBi has formed an Operating Committee to manage the day-to-day operating activities of the company. The Operating Committee is led by Steve Ward and also includes Thomas B. Loring (Senior Vice President Worldwide Product & Technology Development), James T. Hook (Senior Vice President, North American Sales), Jean-Jacques Martin (Senior Vice President, SBi International), Scott Ludecker (Vice President, Worldwide Diabetes and Limb Preservation Systems) and James L. O’Connor (Vice President, Worldwide Regulatory, Quality and Clinical Affairs, Surgeons Ethics & Compliance).

Leave a Comment

Your email address will not be published. Required fields are marked *

*